Literature DB >> 26826417

Intramedullary gangliogliomas: histopathologic and molecular features of 25 cases.

Marco Gessi1, Evelyn Dörner2, Verena Dreschmann2, Manila Antonelli3, Andreas Waha2, Felice Giangaspero4, Astrid Gnekow5, Torsten Pietsch2.   

Abstract

Gangliogliomas are uncommon glioneuronal tumors, which usually arise in the cerebral hemispheres and occasionally in the brain stem. Gangliogliomas occurring in the spinal cord are extremely rare. In this study, we analyzed the clinical, histopathologic, and molecular features of 25 spinal gangliogliomas. The cases included in our series affected mostly children and young adults (15 males and 10 females; mean age, 20 years; median age, 14 years; age range, 1-72 years) and were predominantly localized in the cervical and thoracic spine. From the clinical point of view (detailed follow-up available for 9 pediatric cases; mean follow-up: 2 years 10 months; range, 3 months to 5 years 10 months), most patients showed stable disease after subtotal resection. Radiotherapy was rarely used as adjuvant treatment. Histologically, gangliogliomas (WHO grade I) (21 cases) showed features largely similar to their supratentorial counterparts. Anaplastic gangliogliomas (World Health Organization grade III) (4 cases) showed features of anaplasia (including high cellularity and increased mitotic and proliferation activity). From a molecular point of view, only 2 tumors (2/19, 11%) harbored a BRAF(V600E) mutation. In conclusion, although spinal gangliogliomas display histologic and clinical features similar to their supratentorial counterparts, they show a relatively low frequency of BRAF(V600E) mutations, alteration otherwise common in hemispheric and brain stem gangliogliomas.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Anaplastic ganglioglioma; BRAF; BRAF(V600E); Ganglioglioma; Immunohistochemistry; Spinal cord

Mesh:

Substances:

Year:  2015        PMID: 26826417     DOI: 10.1016/j.humpath.2015.09.041

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  6 in total

1.  Pediatric intracranial primary anaplastic ganglioglioma.

Authors:  Wolf Lüdemann; Rouzbeh Banan; Christian Hartmann; Helmut Bertalanffy; Concezio Di Rocco
Journal:  Childs Nerv Syst       Date:  2016-12-05       Impact factor: 1.475

2.  Impact of surgery, adjuvant treatment, and other prognostic factors in the management of anaplastic ganglioglioma.

Authors:  Supriya Mallick; Rony Benson; Wineeta Melgandi; Prashanth Giridhar; G K Rath
Journal:  Childs Nerv Syst       Date:  2018-03-29       Impact factor: 1.475

3.  The genetic landscape of ganglioglioma.

Authors:  Melike Pekmezci; Javier E Villanueva-Meyer; Benjamin Goode; Jessica Van Ziffle; Courtney Onodera; James P Grenert; Boris C Bastian; Gabriel Chamyan; Ossama M Maher; Ziad Khatib; Bette K Kleinschmidt-DeMasters; David Samuel; Sabine Mueller; Anuradha Banerjee; Jennifer L Clarke; Tabitha Cooney; Joseph Torkildson; Nalin Gupta; Philip Theodosopoulos; Edward F Chang; Mitchel Berger; Andrew W Bollen; Arie Perry; Tarik Tihan; David A Solomon
Journal:  Acta Neuropathol Commun       Date:  2018-06-07       Impact factor: 7.801

4.  Clinical and molecular characterization of a multi-institutional cohort of pediatric spinal cord low-grade gliomas.

Authors:  Sydney T Grob; Liana Nobre; Kristen R Campbell; Kurtis D Davies; Scott Ryall; Dara L Aisner; Lindsey Hoffman; Shadi Zahedi; Andrew Morin; Michele Crespo; Anandani Nellan; Adam L Green; Nicholas Foreman; Rajeev Vibhakar; Todd C Hankinson; Michael H Handler; Cynthia Hawkins; Uri Tabori; B K Kleinschmidt-DeMasters; Jean M Mulcahy Levy
Journal:  Neurooncol Adv       Date:  2020-08-24

Review 5.  Anaplastic gangliogliomas of the spinal cord: a scoping review of the literature.

Authors:  Nikolaos Vlachos; Marios G Lampros; Andreas Zigouris; Spyridon Voulgaris; George A Alexiou
Journal:  Neurosurg Rev       Date:  2021-07-27       Impact factor: 3.042

6.  Genomic Landscape of Intramedullary Spinal Cord Gliomas.

Authors:  Ming Zhang; Rajiv R Iyer; Tej D Azad; Qing Wang; Tomas Garzon-Muvdi; Joanna Wang; Ann Liu; Peter Burger; Charles Eberhart; Fausto J Rodriguez; Daniel M Sciubba; Jean-Paul Wolinsky; Ziya Gokaslan; Mari L Groves; George I Jallo; Chetan Bettegowda
Journal:  Sci Rep       Date:  2019-12-10       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.